Xi Ding

Sun Yat-sen University — China

Medicine · Health Sciences

16h-index720citations42works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(22), Thyroid Disorders and Treatments(8), Head and Neck Surgical Oncology(8), Lung Cancer Treatments and Mutations(7), Lung Cancer Research Studies(7)

Publications42 total

TQB2450 plus intensity-modulated radiotherapy in recurrent nasopharyngeal carcinoma: An open-label, single-arm, phase II trial
Med·2025
ASO Visual Abstract: Endoscopic Transoropharyngeal Retropharyngeal Lymph Node (RPLN) Dissection for RPLN Recurrence Nasopharyngeal Carcinoma
Annals of Surgical Oncology·2025
Endoscopic Transoropharyngeal Retropharyngeal Lymph Node (RPLN) Dissection for RPLN Recurrence Nasopharyngeal Carcinoma
Annals of Surgical Oncology·2025· 1 cited
The association between life satisfaction, depressive symptoms, and common comorbid disorders during the COVID‐19 pandemic
Applied Psychology Health and Well-Being·2025· 2 cited
Radiation-induced rhinosinusitis in patients with nasopharyngeal carcinoma
Radiotherapy and Oncology·2025· 1 cited
Comorbidity Patterns and Associated Factors of thyroid related disorders: A community-based cross-sectional study in Chinese population
2025Open Access
Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal Carcinoma
NEJM Evidence·2025· 2 cited
Characteristics and treatment of epistaxis in nasopharyngeal carcinoma
Oral Oncology·2024· 3 cited
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinoma
Cell Reports Medicine·2024· 6 citedOpen Access
<i>Lachnoclostridium</i> intestinal flora is associated with immunotherapy efficacy in nasopharyngeal carcinoma
Head & Neck·2024· 7 cited
Relationship Between Urinary Iodine Concentration and the Prevalence of Thyroid Nodules and Subclinical Hypothyroidism
Hormone and Metabolic Research·2024
A novel endoscopic nasopharyngectomy by low‐temperature plasma radiofrequency ablation in localized recurrent nasopharyngeal carcinoma
Head & Neck·2023· 5 cited
Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial
Cell Reports Medicine·2023· 22 citedOpen Access
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 study
EClinicalMedicine·2023· 17 citedOpen Access
Induction chemotherapy plus radiotherapy alone versus cisplatin-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: An open-label, non-inferiority, randomized phase 3 trial.
Journal of Clinical Oncology·2023· 3 cited
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
The Lancet·2023· 100 cited
Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study
Journal of Clinical Oncology·2023· 64 citedOpen Access
The Impact of COVID-19 Vaccination on Plasma Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma Patients: A Real-World Study
SSRN Electronic Journal·2023Open Access
Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinoma
Med·2022· 21 citedOpen Access
Comprehensive immune landscape and molecular characteristics of clinical responses to chemotherapy, antiangiogenic agents, and PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma.
Journal of Clinical Oncology·2022
page 1 of 3Next →

Frequent Co-authors

You‐Ping Liu(27), Ming‐Yuan Chen(24), Xiong Zou(16), Rui You(15), Yan‐Feng Ouyang(15), Yi‐Jun Hua(13), Yu‐Long Xie(12), Yong‐Long Liu(12), Chongyang Duan(11), Siyuan Chen(10), Qi Yang(8), Zheng‐Kai Feng(8), Chen-Mei Gu(8), Weijing Zhang(8), Pei‐Yu Huang(8), Zhiqiang Wang(7), Mingqian He(7), Mengxia Zhang(7), Chao Lin(6), Ruo-Qi Xie(6)